Table 1 Age-standardized incidence, mortality, prevalence, YLL, YLD, and DALY rates in 2016
From: Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
Variable | Hodgkin’s lymphoma | Non-Hodgkin’s lymphoma | ||
|---|---|---|---|---|
Numbers (thousand) | Age-standardized rates (per 100,000) | Numbers (thousand) | Age-standardized rates (per 100,000) | |
Incidence | 6.95 (5.50–8.66) | 0.46 (0.36–0.57) | 68.50 (57.30–72.35) | 4.29 (3.61–4.52) |
Mortality | 2.92 (2.40–3.79) | 0.19 (0.16–0.25) | 37.64 (31.36–40.23) | 2.45 (2.06–2.61) |
Prevalence | 26.36 (20.37–32.38) | 1.75 (1.35–2.13) | 237.61 (199.02–251.96) | 14.94 (12.64–15.82) |
YLLs | 87.75 (73.50–115.04) | 5.77 (4.79–7.61) | 1,074.94 (895.46–1150.27) | 69.27 (58.65–73.96) |
YLDs | 2.83 (1.91–3.88) | 1.86 (1.27–2.55) | 22.37 (15.39–30.39) | 1.40 (0.96–1.89) |
DALYs | 90.58 (75.80–118.58) | 5.95 (4.94–7.83) | 1,097.31 (915.34–1172.83) | 70.67 (59.87–75.38) |